CompletedPhase 4

Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis

India31 participantsStarted 2010-07

Plain-language summary

The purpose of this study is to determine whether there itraconazole is effective in the treatment of chronic cavitary pulmonary aspergillosis

Age range14 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Clinical symptoms: -presence of chronic pulmonary/systemic symptoms lasting ≥ six weeks.
✓. Radiological findings:
✓. Microbiological/Immunological findings: Positive results in the aspergillus precipitin test, demonstration of aspergillus hyphae in sputum or BAL fluid or cultures of BAL/sputum growing aspergillus species.
✓. The diagnosis of CCPA will be made if
✓. Patient satisfies at least 1, 2a or 2b and/ or any of the 3rd criteria.
✓. FNAC from the cavity wall will be considered in atypical cases

clinical improvement in cough and hemoptysis

Timeframe: 6 months

NCT IDNCT01259336

SponsorPost Graduate Institute of Medical Education and Research, Chandigarh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-06